Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma
Cody A. Ramirez(James S. McDonnell Foundation), Todd A. Fehniger(Washington University in St. Louis), Sweta Desai(Washington University in St. Louis), Marcus P. Watkins(Washington University in St. Louis), Susanna Kiwala(Washington University in St. Louis), Erica K. Barnell(Washington University in St. Louis), Elena Ocheredko(Addgene), Amanda F. Cashen(Washington University in St. Louis), Vladislav Belousov(Addgene), Malachi Griffith(Washington University in St. Louis), David A. Russler‐Germain(Washington University in St. Louis), Alexander Bagaev(Addgene), Michelle Becker‐Hapak(Washington University in St. Louis), Zachary L. Skidmore(James S. McDonnell Foundation), Catrina C. Fronick(Washington University in St. Louis), Jasreet Hundal(James S. McDonnell Foundation), Felicia Gomez(James S. McDonnell Foundation), Jason Walker(James S. McDonnell Foundation), Robert S. Fulton(St. Jude Children's Research Hospital), Timothy Schappe(Washington University in St. Louis), Neha Mehta–Shah(The University of Texas MD Anderson Cancer Center), Kilannin Krysiak(Washington University in St. Louis), Brad S. Kahl(UW Health University Hospital), Nancy L. Bartlett(Washington University in St. Louis), Ethan McClain(Washington University in St. Louis), Felix Frenkel(Addgene), Thomas B. Mooney(James S. McDonnell Foundation), Robert D. Schreiber(Parker Institute for Cancer Immunotherapy), Ravshan Ataullakhanov(Federal Medical-Biological Agency), Olga Kudryashova(Addgene), Onyinyechi C. Onyeador(Washington University in St. Louis), Kartik Singhal(Washington University in St. Louis), Obi L. Griffith(Washington University in St. Louis)
Cited by 12
Related Papers
The complete sequence of a human genome
|Science|2022|3.3k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k